Roza Khalilova
Physician Assistant · Brooklyn, NYNPI 1194055491
Payments from drug & device makers
Across 298 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- AbbVie$936
- Scilex Pharmaceuticals Inc.$525
- SK Life Science, Inc.$488
- Collegium Pharmaceutical, Inc.$476
- Eisai Inc.$349
- plus $3K from 33 others
What the payments were for
- Travel & lodging$601%
- Food & beverage$6,50297%
- Education$1072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,669 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $108,454 |
| Nurtec OdtRimegepant Sulfate | 50 | $69,437 |
| Dihydroergotamine Mesylate | 58 | $59,310 |
| UbrelvyUbrogepant | 46 | $42,819 |
| QuliptaAtogepant | 29 | $30,400 |
| Diclofenac Sodium | 59 | $29,421 |
| VimpatLacosamide | 15 | $27,632 |
| ZtlidoLidocaine | 41 | $27,381 |
| PamelorNortriptyline Hcl | 12 | $25,650 |
| Oxtellar XrOxcarbazepine | 13 | $18,520 |
| Xtampza ErOxycodone Myristate | 23 | $18,484 |
| Doxepin Hcl | 90 | $18,287 |
| BriviactBrivaracetam | 12 | $17,826 |
| AptiomEslicarbazepine Acetate | 11 | $13,605 |
| Carbamazepine ErCarbamazepine | 58 | $11,123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $38 | $108,45413 claims |
| PfizerNurtec Odt, Lyrica | $160 | $76,12961 claims |
| AbbVieUbrelvy, Qulipta | $936 | $73,21975 claims |
| UCB, Inc.Vimpat, Briviact | $1,171 | $45,45827 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $525 | $27,38141 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $476 | $18,48423 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $107 | $13,60511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Brooklyn
- Kaitlyn NelsonBrooklyn$289K
- Melissa VelezBrooklyn$68K
- Steven KongBrooklyn$66K
- Hong ChenBrooklyn$57K
- Lindsey AxtBrooklyn$52K
- Gregory CelestinBrooklyn$41K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.